Quincy Medical Group is pleased to announce that Dr. Abram Geisendorfer, Dr. Eric Sieck, and Dr. Robert Weller are now offering a new treatment option for patients undergoing cataract surgery that reduces or eliminates the need for costly prescription eye drops.  The time-released medication administered during surgery provides convenience and cost-savings for patients, while alleviating compliance concerns for practitioners.

While patient outcomes and satisfaction are high following cataract surgery, the post-operative eye drop regimen is often the most difficult aspect of the procedure. In addition to the need to follow a strict dosing schedule, eye drops often cost hundreds of dollars, resulting in financial burden. Dropless Cataract Surgery may reduce or eliminate the high cost of prescription medications routinely prescribed, while providing a simpler, less complex recovery.

Traditionally, patients who undergo cataract surgery must adhere to an eye drop schedule that includes several types of drops used for three to four weeks. These drops reduce the risk of inflammation and infection, and are a critical part of ensuring successful outcomes. However, complications arise when cataract patients miss a scheduled dose, are physically unable to instill the drops, have to rely on the availability of a caregiver to administer the drops or when the high cost precludes the purchase of the prescribed drops.

During Dropless Cataract Surgery, a sterile, compounded formulation of antibiotics and anti-inflammatory medication is deposited in the back of the eye (the vitreous). The time-released delivery of the drugs helps fight infection and inflammation during the recovery period. Administering the medication at the time of surgery eliminates concerns about patient compliance associated with the traditional eye drop regimen.

“The introduction of this important treatment option helps us reach the ultimate goal for our patients – better vision without complications and a positive patient experience,” said Quincy Medical Group Ophthalmologist, Dr. Abram Geisendorfer.

For more information on Dropless Cataract Surgery or to schedule an appointment for a cataract evaluation, please call 217-222-6550, ext. 3860